Our Mission
The mission of the NJ Branch of American Society of Addiction Medicine (NJ – ASAM) is to advance the treatment of addiction through education of physicians, physicians-in-training, and other health professionals. Additionally, the Society promotes research, prevention, and implementation of evidence-based treatment. The NJ Society of Addiction Medicine offers high-quality, evidence-based Continuing Medical Education to enable physicians and other health professionals to improve the treatment of patients with substance use disorders. NJSAM courses draw upon the latest research and clinical advances in the scientific and medical communities and feature top experts in the field. NJSAM was awarded “Accreditation with Commendation” by ACCME through the Institute for Medical Quality. Accreditation with Commendation is the highest level of accreditation and is awarded to only a small percentage of CME providers.
- Local and national education opportunities
- Local discussions and journal clubs offering discussion with colleagues on current clinical topics and research
- Outreach to community stakeholders and physicians to improve recognition and treatment of addiction
- Website with links to areas in addiction medicine
- Monthly e-mail newsletters
- Social media outreach (Twitter, Facebook)
- NJ-ASAM provides the voice of the addiction medicine specialist on public policy and clinical issues in New Jersey
- NJ-ASAM develops position statements on key policy issues, setting the framework for debate and discussion
- Advocates for parity for addiction treatment including in health care reform
- Advocates for evidence-based treatment of opioid dependence including in rural areas and in the criminal justice system
- Trains physicians in Narcotic Treatment Programs and publishes a guideline for physicians in these programs
- Trains physicians in the use of buprenorphine in office-based practice
- Works to prevent diversion of prescription medications while opposing ineffective regulations
- Works to ensure insurance coverage for evidence-based treatment of addiction